ahlam1399
08-28-2015, 10:34 PM
Baxalta in talks to buy U.S. hematology-oncology specialist ? Bloomberg
Aug 28 (Reuters) - Drugmaker Baxalta Inc is working with bankers to buy a U.S.-based hematology and oncology specialist valued at about $2 billion, Bloomberg reported, citing people familiar with the...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=ECW_AHVEyN8:1q51YxdRwXk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=ECW_AHVEyN8:1q51YxdRwXk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=ECW_AHVEyN8:1q51YxdRwXk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=ECW_AHVEyN8:1q51YxdRwXk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=ECW_AHVEyN8:1q51YxdRwXk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/ECW_AHVEyN8
Aug 28 (Reuters) - Drugmaker Baxalta Inc is working with bankers to buy a U.S.-based hematology and oncology specialist valued at about $2 billion, Bloomberg reported, citing people familiar with the...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=ECW_AHVEyN8:1q51YxdRwXk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=ECW_AHVEyN8:1q51YxdRwXk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=ECW_AHVEyN8:1q51YxdRwXk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=ECW_AHVEyN8:1q51YxdRwXk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=ECW_AHVEyN8:1q51YxdRwXk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/ECW_AHVEyN8